Showing 2011-2020 of 2038 results for "".
- Cigna Now Covering Avedro’s FDA-Approved Cross-Linking Procedurehttps://modernod.com/news/cigna-now-covering-avedros-fda-approved-cross-linking-procedure/2479851/Avedro announced that 50 commercial insurance plans now cover Avedro’s FDA-approved corneal cross-linking procedure, following Cigna’s recent announcement that it is covering the Photrexa drug formulations and the KXL System used in the treatment of progressive keratoconus. Other health plans rec
- MacuLogix Launches AMD Academyhttps://modernod.com/news/maculogix-launches-amd-academy/2479861/MacuLogix has launched its AMD Academy, an online learning community for current AdaptDx users, delivering video-based product training and a user forum to facilitate discussion of best practices and answers to user questions. “MacuLogix provides extensive, in-person training to eac
- Oxurion Enrolls First Patient in Phase 2 Study Evaluating THR-317 for Treatment of Idiopathic Macular Telangiectasia Type 1https://modernod.com/news/oxurion-enrolls-first-patient-in-phase-2-study-evaluating-thr-317-for-treatment-of-idiopathic-macular-telangiectasia-type-1/2479863/Oxurion, formerly ThromboGenics, announced that it has enrolled the first patient in a phase 2 open-label multicenter study evaluating the efficacy and safety of intravitreal THR-317, an anti-PIGF (human placental growth factor) antibody, for the treatment of Macular Telangiectasia Type 1 (MacTel
- Sun Pharma Receives FDA Approval for Xelpros to Treat Open-Angle Glaucoma or Ocular Hypertensionhttps://modernod.com/news/sun-pharma-and-sparc-announced-fda-approval-of-xelpros-to-treat-open-angle-glaucoma-or-ocular-hypertension/2479886/Sun Pharmaceutical Industries announced FDA approval of Xelpros (latanoprost ophthalmic emulsion 0.005%) for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension. Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium
- EyeSouth Expands into South Florida Through Affiliation with Florida Eye Microsurgical Institutehttps://modernod.com/news/eyesouth-expands-into-south-florida-through-affiliation-with-florida-eye-microsurgical-institute/2479907/EyeSouth Partners has announced that it has completed a strategic partnership with Florida Eye Microsurgical Institute and Boynton Beach ASC, expanding its presence into the South Florida region. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a l
- Topcon Announces Date for 3rd Annual ISSOCT Conferencehttps://modernod.com/news/topcon-announces-date-for-3rd-annual-issoct-conference/2479931/Topcon Medical Systems has announced that the 3rd Annual ISSOCT Conference will be held on February 10-11, 2019 at the Sanibel Harbour Marriott Resort in Fort Myers, Florida. The world’s leading ophthalmologist
- Allergan Lifts Earnings Target, Says No Drug Price Hikes This Yearhttps://modernod.com/news/allergan-lifts-earnings-target-says-no-drug-price-hikes-this-year/2479979/Allergan raised its yearly earnings forecast on Thursday thanks to rising sales of mainstay product Botox, and said it did not expect to increase drug prices this year, according to a
- Data from BioTime’s OpRegen Program to Be Presented at AAO 2018https://modernod.com/news/data-from-biotimes-opregen-program-to-be-presented-at-aao-2018/2479983/BioTime announced that its abstract “PI/IIa Study of Subretinally Transplanted Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry-Form AMD Patients,” has been accepted for an oral presentation at the upcoming American Academy of Ophthalmology (AAO) meeting taking place from October 27-30
- Eton Pharma Reports Positive Topline Results from Phase 3 Trial of EM-100https://modernod.com/news/eton-pharma-reports-positive-topline-results-from-phase-3-trial-of-em-100/2479990/Eton Pharmaceuticals announced positive topline results for its phase 3 study of EM-100 ophthalmic solution. If approved, EM-100 would be the first topical, preservative-free formulation
- State Strips Ex-USC Medical School Dean of License, Citing ‘An Appalling Lack of Judgment’https://modernod.com/news/state-strips-ex-usc-medical-school-dean-of-license-citing-an-appalling-lack-of-judgment/2479992/The California state agency that regulates physicians ordered USC’s former medical school dean stripped of his license to practice medicine, citing “an appalling lack of judgment” in his use of drugs an